Stock Track | Oscar Health Soars 6% in Pre-Market on Strong 2026 Outlook Despite Q4 Miss

Stock Track

Feb 10

Oscar Health, Inc. (OSCR) shares surged 6.00% during pre-market trading on Tuesday, as investors looked past a disappointing fourth-quarter performance and focused on the company's optimistic financial guidance for 2026 and a newly secured credit facility.

The healthcare technology firm reported Q4 2025 revenue of $2.81 billion, missing analyst estimates of $3.12 billion, and a net loss of $352.61 million. The medical loss ratio also rose sharply to 95.4%. However, the market reaction turned positive as Oscar Health projected a significant turnaround for the full year 2026, forecasting revenue between $18.7 billion and $19.0 billion and earnings from operations in the range of $250 million to $450 million.

Further bolstering investor sentiment was the announcement that the company entered into a $475 million secured revolving credit facility on February 6, 2026. Management stated this move strengthens the balance sheet and provides flexibility to fuel long-term growth, positioning the company to return to profitability in 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1140332255"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1140332255\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1140332255?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-10 19:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1140332255","market":"nz","top_or_hot":-1,"title":"Stock Track | Oscar Health Soars 6% in Pre-Market on Strong 2026 Outlook Despite Q4 Miss","media":"Stock Track","content":"<p>Oscar Health, Inc. (OSCR) shares surged 6.00% during pre-market trading on Tuesday, as investors looked past a disappointing fourth-quarter performance and focused on the company's optimistic financial guidance for 2026 and a newly secured credit facility.</p><p>The healthcare technology firm reported Q4 2025 revenue of $2.81 billion, missing analyst estimates of $3.12 billion, and a net loss of $352.61 million. The medical loss ratio also rose sharply to 95.4%. However, the market reaction turned positive as Oscar Health projected a significant turnaround for the full year 2026, forecasting revenue between $18.7 billion and $19.0 billion and earnings from operations in the range of $250 million to $450 million.</p><p>Further bolstering investor sentiment was the announcement that the company entered into a $475 million secured revolving credit facility on February 6, 2026. Management stated this move strengthens the balance sheet and provides flexibility to fuel long-term growth, positioning the company to return to profitability in 2026.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Oscar Health Soars 6% in Pre-Market on Strong 2026 Outlook Despite Q4 Miss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Oscar Health Soars 6% in Pre-Market on Strong 2026 Outlook Despite Q4 Miss\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-10 19:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Oscar Health, Inc. (OSCR) shares surged 6.00% during pre-market trading on Tuesday, as investors looked past a disappointing fourth-quarter performance and focused on the company's optimistic financial guidance for 2026 and a newly secured credit facility.</p><p>The healthcare technology firm reported Q4 2025 revenue of $2.81 billion, missing analyst estimates of $3.12 billion, and a net loss of $352.61 million. The medical loss ratio also rose sharply to 95.4%. However, the market reaction turned positive as Oscar Health projected a significant turnaround for the full year 2026, forecasting revenue between $18.7 billion and $19.0 billion and earnings from operations in the range of $250 million to $450 million.</p><p>Further bolstering investor sentiment was the announcement that the company entered into a $475 million secured revolving credit facility on February 6, 2026. Management stated this move strengthens the balance sheet and provides flexibility to fuel long-term growth, positioning the company to return to profitability in 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OSCR","symbol_name":"Oscar Health, Inc.","start_time":0,"source_url":"","article_id":"1140332255","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1140332255","pubTimestamp":1770723457,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Oscar Health, Inc. (OSCR) shares surged 6.00% during pre-market trading on Tuesday, as investors looked past a disappointing fourth-quarter performance and focused on the company's optimistic...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OSCR":"Oscar Health, Inc."},"translate_title":"股票追踪|尽管第四季度未达预期，Oscar Health仍因2026年前景强劲而盘前飙升6%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OSCR":1},"content_text":"Oscar Health, Inc. (OSCR) shares surged 6.00% during pre-market trading on Tuesday, as investors looked past a disappointing fourth-quarter performance and focused on the company's optimistic financial guidance for 2026 and a newly secured credit facility.The healthcare technology firm reported Q4 2025 revenue of $2.81 billion, missing analyst estimates of $3.12 billion, and a net loss of $352.61 million. The medical loss ratio also rose sharply to 95.4%. However, the market reaction turned positive as Oscar Health projected a significant turnaround for the full year 2026, forecasting revenue between $18.7 billion and $19.0 billion and earnings from operations in the range of $250 million to $450 million.Further bolstering investor sentiment was the announcement that the company entered into a $475 million secured revolving credit facility on February 6, 2026. Management stated this move strengthens the balance sheet and provides flexibility to fuel long-term growth, positioning the company to return to profitability in 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}